October 01, 2018
Rose
Powerful PCSK9 inhibitors were supposed to revolutionize care for cardiac patients. But insurers and other payers balked at sky-high prices.
from Health https://ift.tt/2Qj9S6C
October 01, 2018
Rose
Health, Health - The New York Times
No comments
Related Posts:
Italy’s Health Care System Groans Under Coronavirus — a Warning to the World- Why Coronavirus Is a Special Risk to Half of Americans
- How the Coronavirus Changed the 2020 Political Campaign
- How to Clean Your Phone to Help Protect Against Coronavirus
- Why Women May Face a Greater Risk of Catching Coronavirus
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment